Bone Marrow Mesenchymal Stromal Cells to Treat Tissue Damage in Allogeneic Stem Cell Transplant Recipients: Correlation of Biological Markers with Clinical Responses-Reference-Cited by-同舟云学术

Bone Marrow Mesenchymal Stromal Cells to Treat Tissue Damage in Allogeneic Stem Cell Transplant Recipients: Correlation of Biological Markers with Clinical Responses

Published:2014-04-17 Issue:5 Volume:32 Page:1278-1288
ISSN:1066-5099
Container-title:STEM CELLS
language:en
Short-container-title:Stem Cells

Author:

Yin Fang¹,Battiwalla Minoo¹,Ito Sawa¹,Feng Xingmin¹,Chinian Fariba¹,Melenhorst Jan Joseph¹²,Koklanaris Eleftheria¹,Sabatino Marianna³,Stroncek David³,Samsel Leigh⁴,Klotz Jeffrey¹,Hensel Nancy F.¹,Robey Pamela G.⁵,Barrett A. John¹

Affiliation:

1. Hematology Branch, NHLBINational Institutes of HealthBethesda Maryland USA

2. The Department of Pathology and Laboratory Medicine, Abramson Cancer CenterPerelman School of Medicine, University of PennsylvaniaPhiladelphia Pennsylvania USA

3. Cell Processing Section, Department of Transfusion Medicine, Clinical Center (CC)National Institutes of HealthBethesda Maryland USA

4. Flow Cytometry Core, NHLBINational Institutes of HealthBethesda Maryland USA

5. Craniofacial and Skeletal Diseases Branch, NIDCRNational Institutes of HealthBethesda Maryland USA

Publisher

Oxford University Press (OUP)

Subject

Cell Biology,Developmental Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/stem.1638

Reference17 articles.

1. Alterations in the Cellular Immune Compartment of Patients Treated with Third-Party Mesenchymal Stromal Cells Following Allogeneic Hematopoietic Stem Cell Transplantation

2. Mesenchymal stem cells in hematopoietic stem cell transplantation